• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VYGON GMBH NUTILINE; LONG-TERM INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VYGON GMBH NUTILINE; LONG-TERM INTRAVASCULAR CATHETER Back to Search Results
Model Number 1252.15
Device Problems Break (1069); Fracture (1260); Material Fragmentation (1261)
Patient Problems Foreign Body In Patient (2687); Device Embedded In Tissue or Plaque (3165)
Event Date 06/26/2020
Event Type  Injury  
Manufacturer Narrative
Affected devices will be returned to vygon for evaluation as part of the complaint investigation.The results of this investigation are still pending and will be reported to fda within thirty days of its conclusion via follow-up mdr.
 
Event Description
Two nutriline broke in the operating room.One of them in a baby, and the other in the preparation.The invasion surgeons had to remove the product.The baby is alive.Only one incident is reportable as it was necessary to surgically removed the catheter.The other sample obviously snapped during catheter preparation.
 
Event Description
Two nutriline broke in the operating room.One of them in a baby, and the other in the preparation.The invasion surgeons had to remove the product.The baby is alive.Only one incident is reportable as it was necessary to surgically removed the catheter.The other sample obviously snapped during catheter preparation.
 
Manufacturer Narrative
The two catheters returned by the customer were examined.Upon flushing both catheters were leaking next to the fixation wing.Microscopic examination showed that both catheters have been partly torn out of the fixation wing.Typically, these complaints are related to tensile traction under influence of the use of alcohol-based disinfectants and/or faulty fixation.As each catheter is leak and flow tested before packaging, we can exclude a manufacturing defect.We do not understand why the customer claimed that one catheter fragmented and had to be removed surgically.They either returned the wrong samples or the complaint description was incorrect.The distributor was unable to solve this contradiction, as due to the pandemic, he did not find any physician at the reporting hospital who witnessed this incident.Each catheter is leak and flow tested during production.The tensile force of the catheter components is randomly checked.Visual tests are carried out for product/component presence, the presence in cavities and the integrity of the product seal.This is the first complaint received for batch no.051219gl and the first complaint received for a ruptured catheter on code 1252.15 within the last 3 years.Regarding catheter leakage at the fixation wing 2 similar complaints were registered within the last three years.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NUTILINE
Type of Device
LONG-TERM INTRAVASCULAR CATHETER
Manufacturer (Section D)
VYGON GMBH
prager ring 100
aachen 52070
GM  52070
MDR Report Key10250455
MDR Text Key198114037
Report Number2245270-2020-00061
Device Sequence Number1
Product Code LJS
Combination Product (y/n)N
PMA/PMN Number
K051690
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 01/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Model Number1252.15
Device Lot Number051219GL
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 07/02/2020
Initial Date FDA Received07/09/2020
Supplement Dates Manufacturer Received07/02/2020
Supplement Dates FDA Received01/12/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-